Tesla's valuation now predominantly reflects the prospects of its electric vehicle manufacturing business. An incremental $70 per share value could add to the stock if optionality value is taken into ...
Tesla, Inc.’s value today goes beyond its current earnings, reflecting the optionality embedded in its frontier technologies like AI-driven autonomy, energy storage, and humanoid robots. Strong TSLA ...
CERS develops the Intercept Blood System for platelets, plasma, and IFC. These are valuable offerings for blood transfusions. CERS Intercept provides a pathogen-reduced transfusion product suite that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback